Teresa Amaral

Dr. Amaral finished her MD at Lisbon University in 2006, simultaneously with her degree in Aeronautic Medicine at the Portuguese Air Force. In 2007 she did her general internship at Centro Hospitalar Lisboa Norte and Hospital Pulido Valente in Lisbon, and in 2008 she started her Medical Oncology Internship. This internship was interrupted in 2009 when she was stationed at the Azores Air Base as part of the Portuguese Air Force medical team for the Air Base. During this time, she was also part of the Portuguese Air Force Medical Evacuation Team. She finished her Medical Oncology residency in 2013, and she is a specialist in Medical Oncology since 2014.
In 2016, she started her Ph.D. at the Skin Cancer Center in Tuebingen, Germany, under the supervision of Prof. Claus Garbe. She defended her Ph.D. thesis on the “Progress in systemic therapy of advanced melanoma between 2011 and 2019” at the Nova Medical School in Lisbon in June 2021, Magna cum Laude. Since 2018, she has been responsible for the biobank from the Skin Cancer Center in Tuebingen, and since 2022, she is also the Head of the Skin Cancer Clinical Trials Center in Tuebingen. Her main research focus is biomarkers associated with response to systemic therapy in advanced melanoma, particularly in patients with brain metastases.
Besides her clinical activity, Dr. Amaral is also Chair of the ESMO Leadership Committee, a member of the ESMO Melanoma and other skin cancers faculty, subject editor of the ESMO guidelines for Melanoma and other skin cancers, and a member of the ESMO-MCBS extended working group.